Having trouble accessing articles? Reset your cache.

Optimer jumps on rumors of a take out

Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) jumped $2.24 (19%) to $13.91 on Tuesday after media reports surfaced

Read the full 158 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE